$46.72
1.08% yesterday
NYSE, Jun 11, 10:10 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Stock price

$46.72
+3.76 8.75% 1M
-0.76 1.60% 6M
+0.92 2.00% YTD
+1.50 3.33% 1Y
+1.04 2.27% 5Y
+19.06 68.90% 10Y
+33.83 262.32% 20Y
NYSE, Closing price Wed, Jun 11 2025
+0.50 1.08%
ISIN
NL0012169213
Symbol
QGEN
Sector

Key metrics

Market capitalization $10.12b
Enterprise Value $10.36b
P/E (TTM) P/E ratio 129.78
EV/FCF (TTM) EV/FCF 20.62
EV/Sales (TTM) EV/Sales 5.24
P/S ratio (TTM) P/S ratio 5.11
P/B ratio (TTM) P/B ratio 2.83
Dividend yield 3.32%
Last dividend (FY25) $1.55
Revenue growth (TTM) Revenue growth 0.66%
Revenue (TTM) Revenue $1.98b
EBIT (operating result TTM) EBIT $494.96m
Free Cash Flow (TTM) Free Cash Flow $502.31m
Cash position $1.15b
EPS (TTM) EPS $0.36
P/E forward 22.88
P/S forward 4.92
EV/Sales forward 5.03
Short interest 4.16%
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a QIAGEN NV forecast:

12x Buy
55%
10x Hold
45%

Analyst Opinions

22 Analysts have issued a QIAGEN NV forecast:

Buy
55%
Hold
45%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,978 1,978
1% 1%
100%
- Direct Costs 716 716
2% 2%
36%
1,262 1,262
2% 2%
64%
- Selling and Administrative Expenses 564 564
3% 3%
29%
- Research and Development Expense 193 193
3% 3%
10%
505 505
11% 11%
26%
- Depreciation and Amortization 9.60 9.60
11% 11%
0%
EBIT (Operating Income) EBIT 495 495
11% 11%
25%
Net Profit 84 84
76% 76%
4%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Business Wire
7 days ago
NEW YORK--(BUSINESS WIRE)--Tracer Biotechnologies, a leader in blood-based molecular diagnostics for cancer, is pleased to announce a strategic partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) to co-develop and commercialize minimal residual disease (MRD) assays for solid tumors on QIAGEN's QIAcuity digital PCR platform. This collaboration aims to deliver highly sensitive, co...
Neutral
Business Wire
10 days ago
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics. The new collaborations with Tracer Biotech...
Neutral
PRNewsWire
10 days ago
BOULDER, Colo. , Jun 2, 2025 /PRNewswire/ -- Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) to develop and commercialize a kit-based version of Foresight's CLARITY™ assay, with the goal of enabling global in vi...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today